Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Motor Activity 249Breast Neoplasms 136Neoplasms 108Prostatic Neoplasms 35Fatigue 35Obesity 25Lung Neoplasms 24Colorectal Neoplasms 24Polycystic Ovary Syndrome 17Colonic Neoplasms 16Ovarian Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 11Lymphoma 11Lymphedema 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Weight Loss 10Rectal Neoplasms 10Multiple Myeloma 10Head and Neck Neoplasms 10Leukemia 9Cardiotoxicity 9Insulin Resistance 8Brain Neoplasms 8Stomach Neoplasms 7Peripheral Nervous System Diseases 7Overweight 6Esophageal Neoplasms 6Cognitive Dysfunction 6

Interventions

Vincristine 1Surveys and Questionnaires 1Saline Solution 1Radiotherapy 1Pemetrexed 1Neuropsychological Tests 1HhAntag691 1Gemcitabine 1Fentanyl 1Exercise 1Cyclophosphamide 1Craniospinal Irradiation 1Control Groups 1Cisplatin 1Central Venous Pressure 1Bupivacaine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infratentorial Neoplasms × Exercise × Clear all
NCT01878617 2025-11-13

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
660 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡